Aesthetic Medical International Holdings Group Ltd. (AIH)
Market Cap | 118.06M |
Revenue (ttm) | 124.15M |
Net Income (ttm) | 19.76M |
Shares Out | 70.84M |
EPS (ttm) | -0.33 |
PE Ratio | n/a |
Forward PE | 13.18 |
Dividend | n/a |
Dividend Yield | n/a |
Trading Day | January 19 |
Last Price | $5.08 |
Previous Close | $5.00 |
Change ($) | 0.08 |
Change (%) | 1.60% |
Day's Open | 5.03 |
Day's Range | 4.90 - 5.19 |
Day's Volume | 100,015 |
52-Week Range | 3.94 - 10.28 |
News
Shenzhen, China, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical servic...
Aesthetic Medical International's (AIH) CEO Pengwu Zhou on Q3 2020 Results - Earnings Call Transcript
Shares of Aesthetic Medical Intl (NASDAQ:AIH) moved higher by 3.1% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share came in at $(0.04) down fro...
About AIH
Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments comprising minimally invasive and energy-based treatments, including laser, ultrasound, and ultraviolet light treatments. The company also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistr... [Read more...]
Industry Medical Care Facilities | IPO Date Oct 25, 2019 |
CEO Dr. Pengwu Zhou | Employees 1,550 |
Stock Exchange NASDAQ | Ticker Symbol AIH |
Analyst Forecasts
According to one analyst, the rating for AIH stock is "Strong Buy" and the 12-month stock price forecast is 7.97.